UNSPSC 51284608: Doripenem monohydrate

This classification denotes a beta-lactam antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4B035T6NKT. European Medicines Agency schedules Doripenem hydrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB26847. Doripenem monohydrate generally arises in the molecular formula C15H24N4O6S2.H2O. The term 'doripenem monohydrate' is a Japanese Accepted Name designation. Most nations, for tariff and trade purposes, schedule doripenem monohydrate under HS 29419000 and SITC 54139.

As of Q4 2014, DORIPENEM MONOHYDRATE remains US FDA's Preferred Term for this commodity. SMILES: C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)CNS(=O)(=O)N)C(=O)O)[C@@H](C)O.O.

UNSPSC 51284608 Doripenem monohydrate is a Commodity code for a specific antibiotic active pharmaceutical ingredient, but the recent state and local opportunities posted under this code show little activity directly aligned with doripenem procurement. Instead, the code captures broader pharmaceutical and medical supply sourcing by state health agencies, county health departments, and municipal fire rescue services. The work actually being solicited spans generic multi-source pharmaceuticals, over-the-counter medical products, naloxone and drug deactivation systems, and emergency medical and first aid supplies — representing the full range of pharmaceutical and acute-care consumable needs in public health and emergency response environments rather than single-ingredient drug manufacturing or sourcing at the doripenem level.

Recent solicitations come from diverse issuing bodies: the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), the Texas Health and Human Services Commission, Seminole County, Florida, and the City of Tampa. Geographic activity includes Minnesota, Texas, and Florida. Representative opportunities include MMCAP's RFP (S1070000015802) for generic multi-source pharmaceuticals and OTC products with proposals due March 26, 2026, Texas HHS's RFI (HHS0017013) for direct-to-manufacturer prescription capabilities posted April 3, 2026, Seminole County's IFB (IFB60459723LAS) for naloxone and drug deactivation systems with bid due July 26, 2023, and the City of Tampa's IFB (26P00145) for medical and first aid supplies for the Fire Department Rescue Division with a response deadline of March 13, 2026 and an estimated contract value of $700,000. The code shows meaningful activity in cooperative purchasing vehicles and multi-award procurement frameworks, with emphasis on compliance with FDA requirements, cGMP certification, and supply chain security standards. Set-asides vary by issuing body — Tampa designated the procurement a sheltered market for certified Small Local Business Enterprises with a 5 percent bid discount, while MMCAP and the Texas RFI do not specify disadvantaged-enterprise restrictions in current materials.